DFG Research Training Group "TJ-Train" (GRK 2318/1)
Tight junctions and their proteins
Molecular features and actions in health and disease
Hypotheses and Aims: cholerae,
Campylobacter concisus and other pathogenic
bacteria release zonula occludens toxins (ZOT) and ZOT-related toxins, which can affect the tight junction of
gastrointestinal epithelia. These toxins are considered to cause diarrhea (leak flux diarrheal mechanism) and
progression of inflammatory bowel diseases (leaky gut concept).
Methods:
The doctoral student will study tight junction structure and function in cell and mouse models,
organoids and human tissue specimens with molecular methods e.g. confocal microscopy and RNA sequencing (including
pathway analysis) and with functional electrophysiological measurements. Effects of the toxins are studied by
cloning and overexpression of toxins and are interpreted in comparison to the effects of whole bacteria and
bacterial supernatants.
Work plan: The central part of this project is concerned with
extra- and intracellular signaling either directly at the epithelium or via the mucosal immune system, which is
studied in co-cultures of epithelial cell models and/or organoids, together with M1-macrophages. Proinflammatory
functionality is finally investigated using an inflammation-prone mouse model.
2nd cohort PhD doctoral student
-
Martina Schneemann
-
Schulz E, Schumann M, Schneemann M, Dony V, Fromm A, Nagel O, Schulzke JD, Bücker R (2021)
Escherichia coli alpha-hemolysin HlyA induces host cell polarity changes, epithelial barrier dysfunction and cell detachment in human colon carcinoma Caco-2 cell model via
PTEN-dependent dysregulation of cell junctions. Toxins
13(8): 520 (22 pages). doi: 10.3390/toxins13080520.
(°IF 4.5)
2nd cohort MD doctoral student
-
Jan-Leo Kaak
-
-
Kaak JL, Lobo de Sá FD, Turner JR, Schulzke JD, Bücker R (2022) Unraveling the intestinal epithelial barrier in cyanotoxin microcystin-treated
Caco-2 cell monolayers.
Ann. NY Acad. Sci. 1516(1): 188-196, doi: 10.1111/nyas.14870 (°IF 6.5)
1st cohortPhD doctoral student
-
Nattramilarasu PK, Lobo de Sá FD, Schulzke JD, Bücker R (2021) Immune-mediated aggravation of the Campylobacter concisus-induced epithelial barrier dysfunction.
Int. J. Mol. Sci.
22(4): 2043 (23 pages). doi: 10.3390/ijms22042043,
Supplement PDF (IF 6.2)
-
Nattramilarasu PK, Bücker R, Lobo de Sá FD,
Fromm A, Nagel O, Lee IM, Butkevych E, Mousavi S, Genger C, Kløve S, Heimesaat MM, Bereswill S, Schweiger MR, Nielsen HL, Troeger H, Schulzke JD (2020) Campylobacter concisus impairs sodium absorption in colonic epithelium via ENaC
dysfunction and claudin-8 disruption. Int. J. Mol. Sci.
21(2): e373 (23 pages)
[PubMed] [WebPage] [PDF]
[Supplements]
(IF 5.9)
-
Lobo de Sá FD, Heimesaat MM, Bereswill S, Nattramilarasu PK, Schulzke JD, Bücker R (2021)
Resveratrol prevents Campylobacter jejuni-induced leaky gut by restoring occludin and claudin-5 in the paracellular leak pathway.
Front. Pharmacol. 12: 640572.
doi: 10.3389/fphar.2021.640572 (IF 6.0)
-
Butkevych E, Lobo De Sá FD, Nattramilarasu PK, Bücker R (2020) Contribution of epithelial apoptosis and subepithelial immune responses in Campylobacter jejuni-induced barrier
disruption
Front. Microbiol. 11: 344 (14 pages)
[PubMed] [WebPage] [PDF]
(IF 5.6)
-
Lobo de Sá FD, Butkevych E, Nattramilarasu PK, Fromm A, Mousavi S, Moos V, Golz JC, Stingl K, Kittler S, Seinige D,
Kehrenberg C, Heimesaat MM, Bereswill S, Schulzke JD*, Bücker R (*corresponding) (2019) Curcumin mitigates immune-induced epithelial barrier dysfunction by
Campylobacter jejuni. Int. J. Mol. Sci.
20(19): 4830 (19 pages) [Pubmed] [WebPage]
[PDF] (IF 4.6)
1st cohort MD doctoral students
Karem Awad
-
Lucas Heils
-
Sholpan Omarova
-
Eduard Butkevych
Project-related publications
If a paper is not accessible, please mail to
.
-
Bücker R, Schulz E, Günzel D, Bojarski C, Lee IM, John LJ, Wiegand S, Janßen T, Wieler LH, Dobrindt U, Beutin L, Ewers C, Fromm M,
Siegmund B, Troeger H, Schulzke JD (2014) α-Haemolysin of
Escherichia coli: a potentiator of inflammatory activity in the colon.
Gut
63: 1893-1901
-
Schumann M, Günzel D, Buergel N, Richter JF,
Troeger H, May C, Fromm A, Sorgenfrei D, Daum S, Bojarski C, Heyman M, Zeitz M, Fromm M, Schulzke JD (2012) Cell polarity-determining proteins Par-3 and PP-1 are involved in
epithelial tight junction defects in celiac disease.
Gut
61: 220-228
-
Bücker R, Krug SM, Rosenthal R, Günzel D, Fromm A, Zeitz M, Chakraborty T, Fromm M, Epple HJ, Schulzke JD (2011)
Aerolysin from Aeromonas hydrophila
perturbs tight junction integrity and cell lesion repair in intestinal epithelial HT-29/B6 cells. J. Infect. Dis.
204: 1283-1292
-
Amasheh M, Fromm A, Krug SM, Amasheh S, Andres S, Zeitz M, Fromm M,
Schulzke JD (2010) TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, pAkt, and NFkB signaling.
J. Cell Sci.
123: 4145-4155
-
Bücker R*, Troeger H* (*shared first authorship), Kleer J, Fromm M,
Schulzke JD (2009) Arcobacter butzleri induces barrier dysfunction in intestinal epithelial cells. J. Infect.
Dis.
200: 756-764
-
Epple HJ, Schneider T, Troeger H, Kunkel D, Allers K, Moos V, Amasheh M, Loddenkemper C, Fromm M, Zeitz M, Schulzke JD
(2009) Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut
58: 220-227
-
Troeger H, Loddenkemper C, Schneider T, Schreier E, Epple HJ, Zeitz M, Fromm M, Schulzke JD (2009)
Structural and functional changes of the duodenum in human norovirus infection. Gut
58: 1070-1077
-
Schumann M, Richter JF, Wedell I, Moos V, Zimmermann-Kordmann M, Schneider T, Daum S, Zeitz M, Fromm M, Schulzke JD
(2008) Mechanisms of epithelial translocation of the a2-gliadin-33mer in celiac sprue.
Gut
57: 747-754
-
Troeger H*, Richter JF* (*shared first authorship), Beutin L, Günzel D, Dobrindt U, Epple HJ, Gitter AH, Zeitz M,
Fromm M, Schulzke JD (2007)
E. coli alpha-hemolysin induces focal leaks in colonic epithelium – a novel mechanism of bacterial translocation.
Cell.
Microbiol.
9: 2530-2540
-
Wahnschaffe U, Ullrich R, Riecken EO, Schulzke JD (2001). Celiac disease-like abnormalities in a subgroup of patients
with irritable bowel syndrome. Gastroenterology
121: 1329-1338
|